Trials / Recruiting
RecruitingNCT06673381
High Sensitive C-reactive Protein to Albumin Ratio in Acute Coronary Syndrome
Prediction of Acute Coronary Syndrome In-hospital Major Adverse Cardiovascular Events by High Sensitivity C- Reactive Protein to Albumin Ratio
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in prediction of in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients
Detailed description
Observational study conducted at coronary care unit(CCU) in sohag university hospital It included patients with ACS diagnosed according to AHA/ACCF guidelines (according to symptoms, ECG findings and serum troponin levels), who had admitted to the CCU. Venous blood samples were instantly collected on admission to the hospital. hs-CRP , serum albumin level were measured. hs-CAR is calculated and the patients divided into two groups: Group A ( patients with high hs-CAR) and group B ( patients with low hs-CAR) In-hospital MACE was regarded as the end point of our study. It was defined as acute heart failure, cardiogenic shock, reinfarction, all-cause death, serious arrhythmia and cardiac death
Conditions
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2024-11-01
- Completion
- 2025-10-01
- First posted
- 2024-11-04
- Last updated
- 2024-11-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06673381. Inclusion in this directory is not an endorsement.